PDCD1 and neoplasm: Notably, we found that knockdown of NANOG significantly promoted the overall number of tumor-infiltrating CD8+ T cells (TILs) or tumor-reactive CD 8+ TILs in tumors treated with anti–PD-1 (Figure 3, E and F).